Merit Medical Systems
The 10-second takeaway
For the quarter ended June 30 (Q2), Merit Medical Systems missed estimates on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share shrank significantly. GAAP earnings per share shrank significantly.
Margins dropped across the board.
Merit Medical Systems booked revenue of $109.9 million. The four analysts polled by S&P Capital IQ expected sales of $112.4 million on the same basis. GAAP reported sales were 9.3% higher than the prior-year quarter's $100.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
EPS came in at $0.15. The three earnings estimates compiled by S&P Capital IQ predicted $0.13 per share. Non-GAAP EPS of $0.15 for Q2 were 29% lower than the prior-year quarter's $0.21 per share. GAAP EPS of $0.09 for Q2 were 36% lower than the prior-year quarter's $0.14 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the quarter, gross margin was 42.8%, 400 basis points worse than the prior-year quarter. Operating margin was 6.2%, 400 basis points worse than the prior-year quarter. Net margin was 3.4%, 270 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $111.7 million. On the bottom line, the average EPS estimate is $0.13.
Next year's average estimate for revenue is $446.6 million. The average EPS estimate is $0.51.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 84 members out of 89 rating the stock outperform, and five members rating it underperform. Among 24 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Merit Medical Systems a green thumbs-up, and give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Merit Medical Systems is outperform, with an average price target of $13.25.
Looking for alternatives to Merit Medical Systems? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Merit Medical Systems to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why Merit Medical Systems Inc is Tanking Today
A third quarter earnings report that came in a bit light on revenue is sending shares south today.
Why Merit Medical Systems Inc. Shares Jumped
Merit Medical Systems crushes the Street's estimates in the third-quarter, but can we trust this stock after recent earnings season inconsistencies?
It's Showtime for Merit Medical Systems